fda warning letter compounding pharmacy bpc-157 An advisory committee voted Thursday to remove restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8-6 votes (with The Food and Drug Administration's

The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link This is the first vote from the FDA's Pharmacy Compounding Advisory Committee on one of 7 peptides up for consideration. While the committee advises through these votes, ultimately the FDA will make FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP 1 products. Unlike FDA approved drugs, these products have not been proven to be safe, effective, or of FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA Warns 25 Firms Over Compounded GLP 1 Claims

SKU: 61679905091 · From swgunbroken.com